Free Trial

ResMed (RMD) Short Interest Ratio & Short Volume

ResMed logo
$237.27 +5.69 (+2.46%)
(As of 12/20/2024 05:45 PM ET)

ResMed Short Interest Data

ResMed (RMD) has a short interest of 7.54 million shares. This marks a 3.15% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.8, indicating that it would take 7.8 days of the average trading volume of 1.02 million shares to cover all short positions.

Current Short Interest
7,540,000 shares
Previous Short Interest
7,310,000 shares
Change Vs. Previous Month
+3.15%
Dollar Volume Sold Short
$1.88 billion
Short Interest Ratio
7.8 Days to Cover
Last Record Date
November 30, 2024
Outstanding Shares
146,796,000 shares
Percentage of Shares Shorted
5.14%
Today's Trading Volume
3,053,157 shares
Average Trading Volume
1,023,162 shares
Today's Volume Vs. Average
298%
Short Selling ResMed?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for ResMed and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RMD Short Interest Over Time

RMD Days to Cover Over Time

RMD Percentage of Float Shorted Over Time

ResMed Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/20247,540,000 shares $1.88 billion +3.2%N/A7.8 $249.02
11/15/20247,310,000 shares $1.72 billion -7.4%N/A7.1 $234.77
10/31/20247,890,000 shares $1.91 billion -8.9%N/A7.7 $242.47
10/15/20248,660,000 shares $2.07 billion +1.1%N/A8.5 $239.18
9/30/20248,570,000 shares $2.09 billion -0.1%N/A8.6 $244.13
9/15/20248,580,000 shares $2.14 billion +0.4%N/A7.9 $248.93
8/31/20248,550,000 shares $2.09 billion -12.6%N/A7.9 $245.02
8/15/20249,780,000 shares $2.22 billion +9.9%N/A9.1 $227.26
7/31/20248,900,000 shares $1.90 billion +5.0%N/A8.4 $213.25
7/15/20248,480,000 shares $1.74 billion -1.2%N/A7.9 $205.31
6/30/20248,580,000 shares $1.64 billion +4.1%N/A7.6 $191.42
6/15/20248,240,000 shares $1.74 billion -16.5%N/A7.3 $211.73
5/31/20249,870,000 shares $2.04 billion -3.3%N/A9.2 $206.33
5/15/202410,210,000 shares $2.25 billion +3.7%N/A9.5 $220.63
4/30/20249,850,000 shares $2.11 billion +23.9%N/A9 $214.04
4/15/20247,950,000 shares $1.47 billion +0.8%N/A7.5 $185.09
3/31/20247,890,000 shares $1.56 billion +3.0%N/A7.8 $198.03
3/15/20247,660,000 shares $1.46 billion +13.3%N/A7.9 $190.10
2/29/20246,760,000 shares $1.17 billion +2.7%N/A7.4 $173.72
2/15/20246,580,000 shares $1.20 billion +4.0%N/A7.4 $182.64
1/31/20246,330,000 shares $1.20 billion +7.5%N/A6.5 $190.20
1/15/20245,890,000 shares $1.02 billion +3.9%N/A5.5 $173.90
12/31/20235,670,000 shares $975.35 million -2.4%N/A4.8 $172.02
12/15/20235,810,000 shares $982.18 million -0.7%N/A4.4 $169.05
11/30/20235,850,000 shares $922.72 million -7.3%N/A3.9 $157.73
11/15/20236,310,000 shares $960.07 million +10.3%N/A3.9 $152.15
10/31/20235,720,000 shares $807.78 million +18.4%N/A3.3 $141.22
10/15/20234,830,000 shares $677.41 million +1.5%N/A2.9 $140.25
9/30/20234,760,000 shares $703.86 million +24.6%N/A3.2 $147.87
9/15/20233,820,000 shares $555.39 million +20.9%N/A2.9 $145.39
8/31/20233,160,000 shares $504.30 million +110.7%N/A2.8 $159.59
8/15/20231,500,000 shares $275.03 million +19.1%N/A1.6 $183.35
7/31/20231,260,000 shares $280.16 million -5.3%N/A1.7 $222.35
7/15/20231,330,000 shares $295.73 million +11.8%N/A2.1 $222.35
6/30/20231,190,000 shares $260.02 million +15.5%N/A1.9 $218.50
6/15/20231,030,000 shares $225.42 million -28.5%N/A1.7 $218.85
5/31/20231,440,000 shares $303.54 million +38.5%N/A2.4 $210.79
5/15/20231,040,000 shares $241.79 million +2.0%N/A1.9 $232.49
4/30/20231,020,000 shares $245.78 million -11.3%N/A1.8 $240.96
4/15/20231,150,000 shares $258.24 million -19.0%N/A2 $224.56
Did You See Trump’s Bombshell Exec. Order 001? (Ad)

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry. 
3/31/20231,420,000 shares $310.97 million +9.2%1.0%2.3 $218.99
3/15/20231,300,000 shares $270.39 million +20.4%0.9%2 $207.99
2/28/20231,080,000 shares $230.04 million +1.9%0.7%1.7 $213.00
2/15/20231,060,000 shares $227.77 million +25.5%0.7%1.7 $214.88
1/31/2023844,900 shares $192.95 million -0.6%0.6%1.5 $228.37
1/15/2023850,000 shares $185.39 million -15.8%0.6%1.5 $218.10
12/30/20221,010,000 shares $210.21 million +6.3%0.7%1.8 $208.13
12/15/2022950,100 shares $204.31 million -5.9%0.7%1.8 $215.04
11/30/20221,010,000 shares $232.50 million -5.6%0.7%2 $230.20
11/15/20221,070,000 shares $239.28 million -18.3%0.7%2.2 $223.63
10/31/20221,310,000 shares $293.03 million +6.5%0.9%2.6 $223.69
10/15/20221,230,000 shares $260.45 million -8.2%0.9%2.6 $211.75
9/30/20221,340,000 shares $292.52 million -11.3%0.9%2.9 $218.30
9/15/20221,510,000 shares $341.18 million +18.0%1.0%3 $225.95
8/31/20221,280,000 shares $281.50 million -3.0%0.9%2.3 $219.92
8/15/20221,320,000 shares $312.99 million -28.3%0.9%2.4 $237.11
7/31/20221,840,000 shares $442.56 million +18.7%1.3%3.2 $240.52
7/15/20221,550,000 shares $349.53 million +11.5%1.1%2.5 $225.50
6/30/20221,390,000 shares $291.39 million -7.3%1.0%2.3 $209.63
6/15/20221,500,000 shares $304.92 million +15.4%1.0%2.5 $203.28
5/31/20221,300,000 shares $264.50 million -4.4%0.9%2.4 $203.46
5/15/20221,360,000 shares $267.73 million +5.4%0.9%2.4 $196.86
4/30/20221,290,000 shares $257.96 million -1.5%0.9%2.2 $199.97
4/15/20221,310,000 shares $306.82 million +6.5%0.9%2.2 $234.21
3/31/20221,230,000 shares $298.29 million +27.8%0.9%2 $242.51
3/15/2022962,200 shares $235.08 million -16.3%0.7%1.7 $244.31
2/28/20221,150,000 shares $283.76 million -8.0%0.8%2 $246.75
2/15/20221,250,000 shares $294.06 million +44.3%0.9%2.2 $235.25
1/31/2022866,400 shares $198.06 million +9.7%0.6%1.6 $228.60
1/15/2022790,100 shares $199.23 million +3.6%0.6%1.6 $252.16
12/31/2021762,800 shares $198.69 million +3.2%0.5%1.5 $260.48
12/15/2021739,000 shares $189.60 million -13.1%0.5%1.3 $256.56
11/30/2021850,600 shares $216.78 million -8.0%0.6%1.5 $254.85
11/15/2021924,400 shares $242.53 million -11.1%0.6%1.7 $262.37
10/29/20211,040,000 shares $273.43 million +8.8%0.7%2 $262.91
10/15/2021955,600 shares $244.15 million -2.5%0.7%1.9 $255.49
9/30/2021979,800 shares $258.23 million -10.1%0.7%2.1 $263.55
9/15/20211,090,000 shares $316.56 million No Change0.8%2.3 $290.42
8/31/20211,090,000 shares $316.68 million -11.4%0.8%2.1 $290.53
8/13/20211,230,000 shares $338.37 million +16.0%0.9%2.2 $275.10
7/30/20211,060,000 shares $288.11 million No Change0.7%1.8 $271.80
7/15/20211,060,000 shares $264.58 million -10.2%0.7%1.7 $249.60
6/30/20211,180,000 shares $290.89 million -16.3%0.8%1.9 $246.52
6/15/20211,410,000 shares $333.41 million -0.7%1.0%2.2 $236.46
5/28/20211,420,000 shares $292.31 million -9.0%1.0%2.4 $205.85
5/14/20211,560,000 shares $303.98 million +40.5%N/A2.5 $194.86
4/30/20211,110,000 shares $230.78 million -2.6%N/A1.6 $207.91
4/15/20211,140,000 shares $236.76 million +17.2%N/A1.7 $207.68
3/31/2021972,500 shares $184.10 million +5.6%N/A1.5 $189.31
3/15/2021920,600 shares $170.42 million -9.8%N/A1.4 $185.12
Did You See Trump’s Bombshell Exec. Order 001? (Ad)

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry. 
2/26/20211,020,000 shares $198.88 million -14.3%N/A1.7 $194.98
2/12/20211,190,000 shares $238.63 million +9.2%N/A2.1 $200.53
1/29/20211,090,000 shares $235.36 million +0.9%N/A2.1 $215.93
1/15/20211,080,000 shares $230.34 million No ChangeN/A2.3 $213.28
12/31/20201,080,000 shares $226.50 million -4.4%N/A2.3 $209.72
12/15/20201,130,000 shares $233.21 million -3.4%N/A2.3 $206.38
11/30/20201,170,000 shares $245.28 million -20.4%N/A2.3 $209.64
11/15/20201,470,000 shares $315.67 million +9.7%N/A2.9 $214.74
10/30/20201,340,000 shares $240.54 million -8.8%N/A2.4 $179.51
10/15/20201,470,000 shares $261.38 million -3.3%N/A2.5 $177.81
9/30/20201,520,000 shares $260.57 million +2.7%N/A2.6 $171.43
9/15/20201,480,000 shares $259.81 million -11.4%N/A2.4 $175.55
8/31/20201,670,000 shares $301.90 million +3.7%N/A2.5 $180.78
8/14/20201,610,000 shares $284.62 million -9.0%N/A2.3 $176.78
7/31/20201,770,000 shares $358.44 million +0.6%N/A2.6 $202.51
7/15/20201,760,000 shares $343.27 million -18.1%N/A2.6 $195.04
6/30/20202,150,000 shares $412.80 million +54.7%N/A3.1 $192.00
6/15/20201,390,000 shares $223.36 million -18.2%N/A1.9 $160.69
5/29/20201,700,000 shares $273.39 million -11.0%N/A2 $160.82
5/15/20201,910,000 shares $313.47 million +22.4%N/A2.2 $164.12
4/30/20201,560,000 shares $242.30 million -14.3%N/A1.8 $155.32
4/15/20201,820,000 shares $291.51 million +6.4%1.3%2.2 $160.17
3/31/20201,710,000 shares $275.31 million -8.6%1.2%2.1 $161.00
3/13/20201,871,400 shares $299.09 million -16.5%N/A3.4 $159.82
2/28/20202,240,000 shares $271.85 million -5.5%1.6%4.1 $121.36
2/14/20202,370,000 shares $383.25 million +10.8%1.7%4.7 $161.71
1/31/20202,140,000 shares $355.07 million -1.4%1.5%4.3 $165.92
1/15/20202,170,000 shares $378.34 million -4.0%1.5%4.3 $174.35
12/31/20192,260,000 shares $367.00 million +0.9%1.6%4.6 $162.39

RMD Short Interest - Frequently Asked Questions

What is ResMed's current short interest?

Short interest is the volume of ResMed shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 7,540,000 shares of RMD short. Learn More on ResMed's current short interest.

What is a good short interest ratio for ResMed?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RMD shares currently have a short interest ratio of 8.0. Learn More on ResMed's short interest ratio.

Which institutional investors are shorting ResMed?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ResMed: Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Parallax Volatility Advisers L.P., Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, Citigroup Inc., Caas Capital Management LP, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is ResMed's short interest increasing or decreasing?

ResMed saw a increase in short interest in the month of November. As of November 30th, there was short interest totaling 7,540,000 shares, an increase of 3.1% from the previous total of 7,310,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does ResMed's short interest compare to its competitors?

Here is how the short interest of companies compare to ResMed: Boston Scientific Co. (0.83%), Medtronic plc (0.78%), Becton, Dickinson and Company (0.66%), Edwards Lifesciences Co. (1.48%), IDEXX Laboratories, Inc. (1.48%), DexCom, Inc. (2.16%), STERIS plc (0.95%), Insulet Co. (4.35%), Hologic, Inc. (2.75%), Baxter International Inc. (2.42%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short ResMed stock?

Short selling RMD is an investing strategy that aims to generate trading profit from ResMed as its price is falling. RMD shares are trading up $5.69 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ResMed?

A short squeeze for ResMed occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RMD, which in turn drives the price of the stock up even further.

How often is ResMed's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RMD, twice per month. The most recent reporting period available is November, 30 2024.




This page (NYSE:RMD) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners